Exagen (XGN) Total Current Liabilities (2018 - 2026)

Exagen has reported Total Current Liabilities for 9 years, with the latest figure at $12.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 10.23% year-over-year to $12.6 million; the trailing twelve-month figure through Mar 2026 stood at $12.6 million (down 10.23% YoY), and the FY2025 full-year result was $14.2 million, up 4.83% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $12.6 million, down from $14.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $14.2 million in Q4 2025, with the low at $8.6 million in Q2 2023.
• Historically, Total Current Liabilities has averaged $11.0 million across 5 years, with a median of $10.3 million in 2025.
• Annual changes were most pronounced in 2023 — Total Current Liabilities decreased 22.01% — and 2025, when it jumped 59.34%.
• Exagen's Total Current Liabilities stood at $9.6 million in 2022, then advanced by 23.68% to $11.9 million in 2023, then increased by 13.48% to $13.5 million in 2024, then gained by 4.83% to $14.2 million in 2025, then slipped by 11.26% to $12.6 million in 2026.
• The last three Total Current Liabilities figures came in at $12.6 million (Q1 2026), $14.2 million (Q4 2025), and $12.9 million (Q3 2025), per Business Quant data.